These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27824888)

  • 1. Bifunctional Anti-Non-Amyloid Component α-Synuclein Nanobodies Are Protective In Situ.
    Butler DC; Joshi SN; Genst E; Baghel AS; Dobson CM; Messer A
    PLoS One; 2016; 11(11):e0165964. PubMed ID: 27824888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity.
    Lynch SM; Zhou C; Messer A
    J Mol Biol; 2008 Mar; 377(1):136-47. PubMed ID: 18237741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model.
    Chatterjee D; Bhatt M; Butler D; De Genst E; Dobson CM; Messer A; Kordower JH
    NPJ Parkinsons Dis; 2018; 4():25. PubMed ID: 30155513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity.
    Hmila I; Vaikath NN; Majbour NK; Erskine D; Sudhakaran IP; Gupta V; Ghanem SS; Islam Z; Emara MM; Abdesselem HB; Kolatkar PR; Achappa DK; Vinardell T; El-Agnaf OMA
    FEBS J; 2022 Aug; 289(15):4657-4673. PubMed ID: 35090199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
    Teng Y; Zhao J; Ding L; Ding Y; Zhou P
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies.
    Joshi SN; Butler DC; Messer A
    MAbs; 2012; 4(6):686-93. PubMed ID: 22929188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein.
    El-Turk F; Newby FN; De Genst E; Guilliams T; Sprules T; Mittermaier A; Dobson CM; Vendruscolo M
    Biochemistry; 2016 Jun; 55(22):3116-22. PubMed ID: 27096466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-chain Fv Antibodies for Targeting Neurodegenerative Diseases.
    Chia KY; Ng KY; Koh RY; Chye SM
    CNS Neurol Disord Drug Targets; 2018; 17(9):671-679. PubMed ID: 29546836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein.
    Zhou C; Emadi S; Sierks MR; Messer A
    Mol Ther; 2004 Dec; 10(6):1023-31. PubMed ID: 15564134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
    Park JY; Paik SR; Jou I; Park SM
    Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Immunoreactivity Against the C-Terminal Region of the Intracellular α-Synuclein by Exogenous α-Synuclein Aggregates: Possibility of Conformational Changes.
    Izumi Y; Kondo N; Takahashi R; Akaike A; Kume T
    J Parkinsons Dis; 2016 Jun; 6(3):569-79. PubMed ID: 27314756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
    Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
    Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A; Eliezer D; Ladjimi M
    Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies.
    Marvian AT; Koss DJ; Aliakbari F; Morshedi D; Outeiro TF
    J Neurochem; 2019 Sep; 150(5):535-565. PubMed ID: 31004503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-domain antibody-based protein degrader for synucleinopathies.
    Jiang Y; Lin Y; Tetlow AM; Pan R; Ji C; Kong XP; Congdon EE; Sigurdsson EM
    Mol Neurodegener; 2024 May; 19(1):44. PubMed ID: 38816762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death.
    Mahul-Mellier AL; Vercruysse F; Maco B; Ait-Bouziad N; De Roo M; Muller D; Lashuel HA
    Cell Death Differ; 2015 Dec; 22(12):2107-22. PubMed ID: 26138444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequestration of a β-hairpin for control of α-synuclein aggregation.
    Mirecka EA; Shaykhalishahi H; Gauhar A; Akgül Ş; Lecher J; Willbold D; Stoldt M; Hoyer W
    Angew Chem Int Ed Engl; 2014 Apr; 53(16):4227-30. PubMed ID: 24623599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.